SEC Form 4 · accession 0001209191-16-154664
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Tai-Ching Ho
Officer — Chief Development Officer
Period of report
Dec 8, 2016
Accepted (ET)
Dec 12, 2016 · 2:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001F1 | Dec 8, 2016 | S | 200 | $10.8941 | D | 5,520 | D | |
| Common stock, par value $0.0001F2 | holding | — | — | — | 1,000 | I | By Trust | |
| Common stock, par value $0.0001F2 | holding | — | — | — | 1,000 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold at $10.8941
- F2These shares are held in trust for the benefit of the reporting person's child. The reporting person's spouse is a trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.